Krystal Biotech, Inc. Diluted Shares Outstanding (Weighted Average)
Krystal Biotech, Inc. (KRYS) reported Diluted Shares Outstanding (Weighted Average) of 30.66 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-03
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 30.66M shares, a 3.05% increase year-over-year.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 30.51M shares, a 2.13% increase year-over-year.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 30.32M shares, a 1.22% increase year-over-year.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 29.83M shares, a 0.23% decline year-over-year.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 29.95M shares, a 0.71% increase from fiscal 2024.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 29.74M shares, a 7.16% increase from fiscal 2023.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 27.75M shares, a 8.87% increase from fiscal 2022.
- Krystal Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 25.49M shares, a 14.85% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 30.66M shares 10-Q · filed 2026-08-03 | 30.58M shares 10-Q · filed 2026-08-03 | 30.49M shares derived: average of 3 quarters · filed 2026-08-03 | 30.33M shares derived: average of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | 30.51M shares 10-Q · filed 2026-05-04 | 30.41M shares derived: average of 2 quarters · filed 2026-05-04 | 30.22M shares derived: average of 3 quarters · filed 2026-05-04 | 30.10M shares derived: average of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | 30.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 30.07M shares derived: average of 2 quarters · filed 2026-02-17 | 29.97M shares derived: average of 3 quarters · filed 2026-08-03 | 29.95M shares 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | 29.83M shares 10-Q · filed 2025-11-03 | 29.79M shares derived: average of 2 quarters · filed 2026-08-03 | 29.83M shares 10-Q · filed 2025-11-03 | 29.85M shares derived: average of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | 29.75M shares 10-Q · filed 2026-08-03 | 29.82M shares 10-Q · filed 2026-08-03 | 29.86M shares derived: average of 3 quarters · filed 2026-08-03 | 29.87M shares derived: average of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | 29.87M shares 10-Q · filed 2026-05-04 | 29.91M shares derived: average of 2 quarters · filed 2026-05-04 | 29.91M shares derived: average of 3 quarters · filed 2026-05-04 | 29.84M shares derived: average of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | 29.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 29.93M shares derived: average of 2 quarters · filed 2026-02-17 | 29.83M shares derived: average of 3 quarters · filed 2026-02-17 | 29.74M shares 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | 29.90M shares 10-Q · filed 2025-11-03 | 29.77M shares derived: average of 2 quarters · filed 2025-11-03 | 29.67M shares 10-Q · filed 2025-11-03 | 29.42M shares derived: average of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | 29.64M shares 10-Q · filed 2025-08-04 | 29.50M shares 10-Q · filed 2025-08-04 | 29.26M shares derived: average of 3 quarters · filed 2026-02-17 | 29.17M shares derived: average of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | 29.29M shares 10-Q · filed 2025-05-06 | 29.07M shares derived: average of 2 quarters · filed 2026-02-17 | 29.01M shares derived: average of 3 quarters · filed 2026-02-17 | 28.42M shares derived: average of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | 28.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 28.87M shares derived: average of 2 quarters · filed 2026-02-17 | 28.13M shares derived: average of 3 quarters · filed 2026-02-17 | 27.75M shares 10-K · filed 2026-02-17 | 27.75M shares 10-K · filed 2024-02-26 | |||
| 2023-09-30 | 28.89M shares 10-Q · filed 2024-11-04 | 28.89M shares 10-Q · filed 2023-11-06 | 27.77M shares derived: average of 2 quarters · filed 2024-11-04 | 27.39M shares 10-Q · filed 2024-11-04 | 27.38M shares 10-Q · filed 2023-11-06 | 26.74M shares derived: average of 4 quarters · filed 2025-02-19 | ||
| 2023-06-30 | 26.66M shares 10-Q · filed 2024-08-05 | 26.66M shares 10-Q · filed 2023-08-07 | 26.19M shares 10-Q · filed 2024-08-05 | 26.19M shares 10-Q · filed 2023-08-07 | 26.02M shares derived: average of 3 quarters · filed 2025-02-19 | 25.92M shares derived: average of 4 quarters · filed 2025-02-19 | ||
| 2023-03-31 | 25.71M shares 10-Q · filed 2024-05-06 | 25.71M shares 10-Q · filed 2023-05-08 | 25.70M shares derived: average of 2 quarters · filed 2025-02-19 | 25.67M shares derived: average of 3 quarters · filed 2025-02-19 | 25.64M shares derived: average of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | 25.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 25.65M shares derived: average of 2 quarters · filed 2025-02-19 | 25.62M shares derived: average of 3 quarters · filed 2025-02-19 | 25.49M shares 10-K · filed 2025-02-19 | 25.49M shares 10-K · filed 2023-02-27 | |||
| 2022-09-30 | 25.62M shares 10-Q · filed 2023-11-06 | 25.58M shares derived: average of 2 quarters · filed 2023-11-06 | 25.43M shares 10-Q · filed 2023-11-06 | 24.85M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | 25.55M shares 10-Q · filed 2023-08-07 | 25.33M shares 10-Q · filed 2023-08-07 | 24.59M shares derived: average of 3 quarters · filed 2024-02-26 | 23.99M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | 25.11M shares 10-Q · filed 2023-05-08 | 24.11M shares derived: average of 2 quarters · filed 2024-02-26 | 23.48M shares derived: average of 3 quarters · filed 2024-02-26 | 23.16M shares derived: average of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | 23.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 22.66M shares derived: average of 2 quarters · filed 2024-02-26 | 22.51M shares derived: average of 3 quarters · filed 2024-02-26 | 22.20M shares 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | 22.21M shares 10-Q · filed 2022-11-07 | 22.21M shares derived: average of 2 quarters · filed 2022-11-07 | 21.89M shares 10-Q · filed 2022-11-07 | 21.35M shares derived: average of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | 22.20M shares 10-Q · filed 2022-08-08 | 21.73M shares 10-Q · filed 2022-08-08 | 21.06M shares derived: average of 3 quarters · filed 2023-02-27 | 20.71M shares derived: average of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | 21.25M shares 10-Q · filed 2022-05-09 | 20.48M shares derived: average of 2 quarters · filed 2023-02-27 | 20.22M shares derived: average of 3 quarters · filed 2023-02-27 | 19.76M shares derived: average of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | 19.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 19.70M shares derived: average of 2 quarters · filed 2023-02-27 | 19.26M shares derived: average of 3 quarters · filed 2023-02-27 | 18.79M shares 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | 19.68M shares 10-Q · filed 2021-11-08 | 19.03M shares derived: average of 2 quarters · filed 2021-11-08 | 18.48M shares 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | 18.38M shares 10-Q · filed 2021-08-09 | 17.87M shares 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |